Background. Staphylococcus aureus bacteremia (SAB) is commonly associated with cardiac implantable electronic device infection (CIED-I). This usually requires explantation of the device. In cases of SAB in the presence of CIED that is not obviously infected (after examination of the pocket and transesophageal echocardiogram), decision about device removal is less clear. Predicting CIED-I in those cases would be helpful.
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Methods. This case-control study included all adults admitted to the University of Kansas Medical Center with SAB in the presence of a CIED between January 1, 2007 and December 31, 2012, using ICD 9 codes, CIED registry, and microbiology database. Cases had device infection evidenced by pocket infection or CIED related endocarditis; controls did not, over a 12 weeks follow up period. Clinical predictors of CIED-I were evaluated using logistic regression. (OR 6.58, ). Mortality at 30 and 365 days was not significantly different between cases and controls.
Conclusion. Fever, tachycardia and persistent bacteremia were associated with increased risk of CIED-I among patient with SAB, while ESRD and immunosuppression were protective on univariate analysis. Only fever remained significantly associated with CIED-I on multivariate analysis.
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